Teradyne to Announce First Quarter 2025 Results

Business Wire
11 Apr

NORTH READING, Mass., April 10, 2025--(BUSINESS WIRE)--Teradyne, Inc. (NASDAQ: TER) will release financial results for the first quarter 2025 on Monday, April 28, at 5:00 p.m. Eastern Time (ET) or later.

A conference call to discuss the first quarter results, along with management's business outlook, will follow at 8:30 a.m. ET, Tuesday, April 29, 2025.

Interested investors should access the webcast at investors.teradyne.com/events-presentations at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET.

A replay will be available on the Teradyne website at investors.teradyne.com.

About Teradyne

Teradyne (NASDAQ:TER) designs, develops, and manufactures automated test equipment and advanced robotics systems. Its test solutions for semiconductors and electronics products enable Teradyne’s customers to consistently deliver on their quality standards. Its advanced robotics business includes collaborative robots and mobile robots that support manufacturing and warehouse operations for companies of all sizes. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250410171579/en/

Contacts

Traci Tsuchiguchi
Investor Relations
Tel: 978.370.2444
investorrelations@teradyne.com


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10